Methods of treating crohn's disease with anti-il23 specific antibody

MD4423126T2Active Publication Date: 2026-08-31JANSSEN BIOTECH INC

View PDF 0 Cites 0 Cited by

Patent Information

Application Number: MDE20240824T
Authority / Receiving Office: MD · MD
Patent Type: Patents
Current Assignee / Owner
Priority Date: 2022-10-27
Filing Date: 2022-10-27
Publication Date: 2026-08-31
Estimated Expiration: 2042-10-27

Application Information

Patent Timeline

27 Oct 2022

Priority

27 Oct 2022

Application

MDE20240824T

31 Aug 2026

Publication

MD4423126T2

IPC: C07K16/24; A61K39/395; A61P1/00; A61P37/06

CPC: C07K16/244; A61P1/00; A61P37/06; A61K2039/505; A61K2039/54; A61K2039/545

Inventors: GERMINARO Matthew; OLURINDE Mobolaji

Get more patent work done with AI

Run novelty searches—or use them for FTO, design risk, drafting and technical problem-solving.

Explore More Agents

Novelty Search
Search existing technologies and assess novelty
↗
FTO
Analyze whether a product may infringe others' patents
↗
Design FTO
Check prior-design risk for exterior design
↗
Drafting
Draft patent application text based on a technical solution
↗
Find Solutions with TRIZ
Generate feasible solution to solve your technical challenge
↗
IP MCP Servers
Connect trusted patent search and cited evidence to Claude, Cursor or your own AI workflow
↗

Patent Text Reader

Abstract

A method of treating Crohn's disease in a patient administers an IL-23-specific antibody, e.g., guselkumab, at an initial subcutaneous dose and subsequent subcutaneous doses such that the patient responds to the antibody and meets one or more clinical endpoints.

Need to check novelty before this filing date? Find Prior Art